Thu 13 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Dolutegravir | Tivicay | 4.4 Special Warnings and Special Precautions for Use | Sep,2022 |
| Eliglustat | Cerdelga | 4.2 Posology And Method Administration 6.6. Special precautions for disposal and other handling | Sep,2022 |
| Vigabatrin | Sabril | 4.2 Posology And Method Administration 6.6. Special precautions for disposal and other handling | Sep,2022 |
| Cabozantinib | Cometriq | 4.8 Undesirable effects | Oct,2023 |
| Tirzepatide | Mounjaro | 4.8 Undesirable effects | Oct,2023 |
| Semaglutide | Ozempic | 4.8 Undesirable effects | Oct,2023 |
| Paroxetine | Seroxat | 4.8 Undesirable effects | Oct,2023 |
| Insulin Degludec,Liraglutide | Xultophy | 4.8 Undesirable effects | Oct,2023 |
| Liraglutide | Saxenda | 4.8 Undesirable effects | Oct,2023 |
| Semaglutide | Rybelsus | 4.8 Undesirable effects | Oct,2023 |
Last update date: 13/08/2026 at 02:25 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.